The FDA has approved specific formulations for different indications: semaglutide 2.4 mg (Wegovy), liraglutide 3 mg (Saxenda), and tirzepatide (Zepbound) are approved for chronic weight management, while all are approved for diabetes at different doses
Skin texture, lighting, body proportions: all are generated to mimic a plausible journey, often showing a woman in her 40s or 50s, the demographic currently driving Europes GLP-1 interest
Add electrolytes if intake is low, sweating is high, or your provider recommends them
Oral semaglutide must survive stomach acid and cross your intestinal lining, requiring strict fasting protocols to maximize uptake
This single steady cruise level is often used for consistent daily research